Takeda Pharmaceutical Company Limited Plan Assets At Fair Value
Takeda Pharmaceutical Company Limited (TKPHF) had Plan Assets At Fair Value of JPY 347.12 billion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:PlanAssetsAtFairValue · last filed 2025-06-25
- 2025-03-31: Plan Assets At Fair Value 347.12B JPY.
- 2024-03-31: Plan Assets At Fair Value 391.74B JPY.
- 2023-03-31: Plan Assets At Fair Value 345.63B JPY.
- 2022-03-31: Plan Assets At Fair Value 342.50B JPY.
| Period end | Plan Assets At Fair Value |
|---|---|
| 2025-03-31 | 347.12B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 391.74B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 345.63B JPY 20-F · filed 2024-06-26 |
| 2022-03-31 | 342.50B JPY 20-F · filed 2023-06-28 |
| 2021-03-31 | 333.39B JPY 20-F · filed 2022-06-29 |
| 2020-03-31 | 290.71B JPY 20-F · filed 2021-06-29 |
| 2019-03-31 | 303.82B JPY 20-F · filed 2020-06-24 |
| 2018-03-31 | 251.63B JPY 20-F · filed 2019-06-27 |